Acumen Pharmaceuticals (ABOS) Receivables - Other (2023 - 2026)
Acumen Pharmaceuticals (ABOS) reported Receivables - Other of $772000.0 for Q1 2026, up 105.32% on a YoY basis from $376000.0 in Q1 2025, and up 23.52% sequentially from $625000.0 in Q4 2025.
Acumen Pharmaceuticals (ABOS) Receivables - Other (2023 - 2026) Analysis & Trends
Acumen Pharmaceuticals (ABOS) has 4 years of Receivables - Other data on file, last reported at $772000.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Other rose 105.32% year-over-year to $772000.0; the trailing twelve-month figure through Mar 2026 stood at $772000.0 (up 105.32% YoY), and the FY2025 full-year result was $625000.0, up 81.16% from the prior year.
- Receivables - Other improved to $772000.0 in Q1 2026, from $625000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $772000.0 in Q1 2026 to a low of $106000.0 in Q2 2024.
- A 4-year average of $360000.0 and a median of $330000.0 in 2024 frame the typical range for Receivables - Other.
- Peak annual rise in Receivables - Other reached 197.17% in 2025, while the deepest fall reached 41.42% in 2025.
- Tracing ABOS's Receivables - Other over 4 years: stood at $225000.0 in 2023, then surged by 53.33% to $345000.0 in 2024, then soared by 81.16% to $625000.0 in 2025, then increased by 23.52% to $772000.0 in 2026.
- Business Quant data shows ABOS's Receivables - Other at $772000.0 in Q1 2026, $625000.0 in Q4 2025, and $379000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Acumen Pharmaceuticals | 140.98 Mn | 140.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 772,000.00 |
| Mar 31, 2026 | 772,000.00 |
| Dec 31, 2025 | 625,000.00 |
| Dec 31, 2025 | 625,000.00 |
| Sep 30, 2025 | 379,000.00 |
| Sep 30, 2025 | 379,000.00 |
| Jun 30, 2025 | 315,000.00 |
| Jun 30, 2025 | 315,000.00 |
| Mar 31, 2025 | 376,000.00 |
| Mar 31, 2025 | 376,000.00 |
| Dec 31, 2024 | 345,000.00 |
| Dec 31, 2024 | 345,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Jun 30, 2024 | 106,000.00 |
| Jun 30, 2024 | 106,000.00 |
| Mar 31, 2024 | 189,000.00 |
| Mar 31, 2024 | 189,000.00 |
| Dec 31, 2023 | 225,000.00 |
| Dec 31, 2023 | 225,000.00 |